Clinical Trials Directory

Trials / Unknown

UnknownNCT02414802

Study of a Novel Thrombectomy Device to Treat Acute Iliofemoral Deep Venous Thrombosis

Study on the Application of a Novel Aspiration Thrombectomy Device Combined With Catheter-directed Thrombolysis for the Treatment of Acute Iliofemoral Deep Venous Thrombosis

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
40 (estimated)
Sponsor
Xuzhou Medical University · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine whether the novel aspiration thrombectomy device combined with catheter-directed thrombolysis is effective in the treatment of acute iliofemoral deep venous thrombosis (IF-DVT).

Detailed description

Catheter-directed thrombolysis will be performed in eligible patients with acute IF-DVT. A combined mechanical thrombectomy will be used to clear the iliac thrombi in experimental group. The immediate, mid- and long-term outcomes will be recorded. Quantitative data wiil be expressed as mean ± SD, and will be compared with independent-sample t-test or paired-sample t-test. Count data will be expressed as a ratio (or percentage), and the chi-square test or the fisher's exact test will be used for comparisons. A difference with P \< 0.05 will be considered statistically significant. All statistical analyses will be performed using IBM SPSS, version 22.0 (SPSS Inc., Chicago, IL, USA).

Conditions

Interventions

TypeNameDescription
DEVICEa manual spiral thrombus broken suction deviceA manual spiral thrombus broken suction device will be used for thrombectomy before catheter-directed thrombolysis
PROCEDUREcatheter-directed thrombolysiscatheter-directed thrombolysis will be used in both arms
DRUGlow-molecular-weight heparin calciumanticoagulation therapy will be administered via subcutaneous injection of low-molecular-weight heparin calcium (LMWH-Ca 5,000 U/12 h) in both arms at discharge
DRUGurokinaseA total of 100,000 units urokinase once every 4-6 hours will be used during catheter-directed thrombolysis therapy

Timeline

Start date
2014-12-01
Primary completion
2017-12-01
Completion
2017-12-01
First posted
2015-04-13
Last updated
2017-01-18

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT02414802. Inclusion in this directory is not an endorsement.